Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism

Ying, Haoqiang, Kimmelman, Alec C., Lyssiotis, Costas A., Hua, Sujun, Chu, Gerald C., Fletcher-Sananikone, Eliot, Locasale, Jason W., Son, Jaekyoung +23 more·2012·Cell

DOI 10.1016/j.cell.2012.01.058

Cited by (1,006)

Items 401–500 of 1,006

Activated hyaluronan metabolism in the tumor matrix — Causes and consequences
Markku Tammi, Sanna Oikari, Sanna Pasonen‐Seppänen, Kirsi J. Rilla, Päivi Auvinen, Raija Tammi · 2018 · Matrix Biology
The Pentose Phosphate Pathway Dynamics in Cancer and Its Dependency on Intracellular pH
Khalid Omer Alfarouk, Samrein B. M. Ahmed, Robert Lange Elliott, Amanda Benoit, Saad S. Alqahtani, Muntaser Eltayeb Ibrahim, Adil H. H. Bashir, Sari T. S. Alhoufie, Gamal Osman Elhassan, Christian C. Wales et al. · 2020 · Metabolites
Combinatorial strategies to target RAS-driven cancers
Naiara Perurena, Lisa Situ, Karen M. Cichowski · 2024 · Nature reviews. Cancer
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
Chen, Ru, Lai, Lisa A, Sullivan, Yumi, Wong, Melissa, Wang, Lei, Riddell, Jonah, Jung, Linda, Pillarisetty, Venu G., Brentnall, Teresa A., Pan, Sheng · 2017 · Scientific Reports
GSK-3α Promotes Oncogenic KRAS Function in Pancreatic Cancer via TAK1–TAB Stabilization and Regulation of Noncanonical NF-κB
Deepali Bang, Willie Wilson, Meagan B. Ryan, Jen Jen Yeh, Albert S. Baldwin · 2013 · Cancer Discovery
Pancreatic cancer: Current research and future directions
Marco Falasca, Minkyoung Kim, Ilaria Casari · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Alain Michielin, Mikaël J. Pittet · 2024 · Nature reviews. Cancer
Digging deeper through glucose metabolism and its regulators in cancer and metastasis
Majid Ghanavat, Mehdi Shahrouzian, Zeinab Deris Zayeri, Sara Banihashemi, Seyedeh Maryam Kazemi, Najmaldin Saki · 2020 · Life Sciences
A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis
Vincenzo D’Angiolella, Mine Esencay, Michele Pagano · 2012 · Trends in Cell Biology
USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation
Hou, Pingping, Ma, Xingdi, Zhang, Qiang, Wu, Chang-Jiun, Liao, Wenting, Li, Jun, Wang, Huamin, Zhao, Jun, Zhou, Xin, Guan, Carolyn et al. · 2019 · Genes & Development
Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion
Juvekar, Ashish, Hu, Hai, Yadegarynia, Sina, Lyssiotis, Costas A., Ullas, Soumya, Lien, Evan C., Bellinger, Gary, Son, Jaekyoung, Hok, Rosanna C., Seth, Pankaj et al. · 2016 · Proceedings of the National Academy of Sciences
Molecular genetics and cellular events of K-Ras-driven tumorigenesis
Goodwin G. Jinesh, Vaishnavi Sambandam, Smruthi Vijayaraghavan, Kavitha Balaji, S Mukherjee · 2017 · Oncogene
RNA-based therapies: A cog in the wheel of lung cancer defense
Parvez Κhan, Jawed Akhtar Siddiqui, Imayavaramban Lakshmanan, Apar Kishor Ganti, Ravi Salgia, Maneesh Jain, Surinder K. Batra, Mohd Wasim Nasser · 2021 · Molecular Cancer
The Pentose Phosphate Pathway in Cancer: Regulation and Therapeutic Opportunities
Noorhan Ghanem, Chirine El‐Baba, Khaled Araji, Riyad El‐Khoury, Julnar A. Usta, Nadine Darwiche · 2021 · Chemotherapy
Synthetic Lethal Vulnerabilities in <i>KRAS</i>-Mutant Cancers
Aguirre, Andrew J., Hahn, William C. · 2018 · Cold Spring Harbor Perspectives in Medicine
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis
Roberta Palorini, Giuseppina Votta, Yuri Pirola, Humberto De Vitto, Sara De Palma, Cristina Airoldi, Michele Vasso, Francesca Ricciardiello, Pietro Paolo Lombardi, Claudia Cirulli et al. · 2016 · PLoS Genetics
Epithelial-mesenchymal transition induction is associated with augmented glucose uptake and lactate production in pancreatic ductal adenocarcinoma
Menghan Liu, Lake‐Ee Quek, Ghazal Sultani, Nigel A. Turner · 2016 · Cancer & Metabolism
Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E
Xuhui Ma, Boya Li, Jie Liu, Yan Fu, Yongzhang Luo · 2019 · Journal of Experimental & Clinical Cancer Research
UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation
Harri M. Itkonen, Nikolai Engedal, Eshrat Babaie, Morten Luhr, Ingrid Jenny Guldvik, Sarah Jane Pauline Minner, Juliane Hohloch, Maria‐Christina Tsourlakis, Thorsten Schlomm, Ian Geoffrey Mills · 2014 · Oncogene
Extrinsic KRAS signaling shapes the pancreatic microenvironment through fibroblast reprogramming
Velez-Delgado, Ashley, Donahue, Katelyn L., Brown, Kristee L., Du, Wenting, Irizarry-Negron, Valerie, Menjivar, Rosa E., Lasse Opsahl, Emily L., Steele, Nina G., The, Stephanie, Lazarus, Jenny et al. · 2022 · Cellular and Molecular Gastroenterology and Hepatology
A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling
Bo Kong, Weiwei Wu, Tao Cheng, Anna Melissa Schlitter, Chengjia Qian, Philipp Bruns, Ziying Jian, Carsten Jäger, Ivonne Regel, Susanne Raulefs et al. · 2015 · Gut
GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells
Jaime Abrego, Venugopal Gunda, Enza Vernucci, Surendra Kumar Shukla, Ryan J. King, Aneesha Dasgupta, Gennifer D. Goode, Divya Murthy, Fang Yu, Pankaj K. Singh · 2017 · Cancer Letters
Metabolic Plasticity of Tumor Cell Mitochondria
Giuseppe Cannino, Francesco Ciscato, Ionica Masgras, Carlos Sànchez‐Martìn, Andrea Rasola · 2018 · Frontiers in Oncology
Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
James R. W. Conway, David Herrmann, TR Jeffry Evans, Jennifer P. Morton, Paul Timpson · 2018 · Gut
Positive feedback nanoamplifier responded to tumor microenvironments for self-enhanced tumor imaging and therapy
Ying Zhang, Lin Lin, Liang Liu, Feng Liu, Sheng Shu, Huayu Tian, Xuesi Chen · 2019 · Biomaterials
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening
Antonella Sistigu, Martina Musella, Claudia Galassi, Ilio Vitale, Ruggero D. Maria · 2020 · Frontiers in Immunology
Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation
Yang Zhang, Yi Xu, Wenyun Lu, Jonathan M. Ghergurovich, Lili Guo, Ian A. Blair, Joshua D. Rabinowitz, Xiaolu Yang · 2020 · Cell Metabolism
Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death
Chi Zhou, Wenxin Li, Liang Zhenxing, Xianrui Wu, Sijing Cheng, Jianhong Peng, Kaixuan Zeng, Weihao Li, Ping Lan, Xin Yang et al. · 2024 · Nature Communications
AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor–Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment
Natalie A. Daurio, Stephen W. Tuttle, Andrew J. Worth, Ethan Y. Song, Julianne M. Davis, Nathaniel W. Snyder, Ian A. Blair, Constantinos Koumenis · 2016 · Cancer Research
Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment
Zobeida Cruz‐Monserrate, Christina Lynn Roland, Defeng Deng, Thiruvengadam Arumugam, Anna Moshnikova, Oleg A. Andreev, Yana K. Reshetnyak, Craig D. Logsdon · 2014 · Scientific Reports
FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer
Shunrong Ji, Yi Qin, Chen Liang, Run Huang, Si Shi, Jiang Liu, Kaizhou Jin, Dingkong Liang, Wenyan Xu, Bo Zhang et al. · 2016 · Clinical Cancer Research
Targeting O-GlcNAcylation to develop novel therapeutics
Yi Zhu, Gerald Warren Hart · 2020 · Molecular Aspects of Medicine
Metabolomics, metabolic flux analysis and cancer pharmacology
Lingfan Liang, Fei Sun, Hongbo Wang, Zeping Hu · 2021 · Pharmacology & Therapeutics
Risk factors for pancreatic cancer: underlying mechanisms and potential targets
Thomas R. Kolodecik, Christine Shugrue, Munish Ashat, Edwin C. Thrower · 2014 · Frontiers in Physiology
MicroRNA-124 Reduces the Pentose Phosphate Pathway and Proliferation by Targeting PRPS1 and RPIA mRNAs in Human Colorectal Cancer Cells
Zhaoping Qiu, Weijie Guo, Qifeng Wang, Zhiao Chen, Shenglin Huang, Fangyu Zhao, Ming Yao, Yingjun Zhao, Xianghuo He · 2015 · Gastroenterology
Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma
Huai‐Qiang Ju, Haoqiang Ying, Tian Tian, Jianhua Ling, Jie Fu, Lu Yu, Min Wu, Lifeng Yang, Abhinav Achreja, Gang Chen et al. · 2017 · Nature Communications
High-resolution three-dimensional NMR structure of the KRAS proto-oncogene promoter reveals key features of a G-quadruplex involved in transcriptional regulation
Abdelaziz Kerkour, Julien Marquevielle, С. А. Иващенко, Liliya A. Yatsunyk, Jean‐Louis Mergny, Gilmar F. J. Salgado · 2017 · Journal of Biological Chemistry
Angiogenin/ribonuclease 5 is an EGFR ligand and a serum biomarker for erlotinib sensitivity in pancreatic cancer
Ying-Nai Wang, Heng-Huan Lee, Chao-Kai Chou, Wen-Hao Yang, Yong-Kun Wei, Chun-Te Chen, Jun Yao, J. Hsu, Ci-Hui Zhu, Hao-Qiang Ying et al. · 2018 · Cancer Cell
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting
Utpreksha Vaish, Tejeshwar Jain, Abhi C. Are, Vikas Dudeja · 2021 · International Journal of Molecular Sciences
Cancer-associated fibroblasts employ NUFIP1-dependent autophagy to secrete nucleosides and support pancreatic tumor growth
Meng Yuan, Bo Tu, Hengchao Li, Huanhuan Pang, Nan Zhang, Minghe Fan, Jingru Bai, Wei Wang, Zhaoqi Shu, Christopher C. DuFort et al. · 2022 · Nature Cancer
TIGAR, TIGAR, burning bright
Pearl Lee, Karen H. Vousden, Eric C. Cheung · 2014 · Cancer & Metabolism
PRKCI promotes immune suppression in ovarian cancer
Sarkar, Sharmistha, Bristow, Christopher A., Dey, Prasenjit, Rai, Kunal, Perets, Ruth, Ramirez-Cardenas, Alejandra, Malasi, Shruti, Huang-Hobbs, Emmet, Haemmerle, Monika, Wu, Sherry Y. et al. · 2017 · Genes & Development
In vivo genetic dissection of tumor growth and the Warburg effect
Chengwei Wang, Arunima Purkayastha, Kevin T. Jones, Shivani K Thaker, Utpal K. Banerjee · 2016 · eLife
RNA G-Quadruplexes in Kirsten Ras ( KRAS ) Oncogene as Targets for Small Molecules Inhibiting Translation
Giulia Miglietta, Susanna Cogoi, Jessica Marinello, Giovanni Capranico, Alexander S. Tikhomirov, Andrey Egorovich Shchekotikhin, Luigi Emilio Xodo · 2017 · Journal of Medicinal Chemistry
Transcriptional regulation of O-GlcNAc homeostasis is disrupted in pancreatic cancer
Kevin Qian, Simeng Wang, Minnie Fu, Jinfeng Zhou, Jay Prakash Singh, Min‐Dian Li, Yunfan Yang, Kaisi Zhang, Jing Wu, Yongzhan Nie et al. · 2018 · Journal of Biological Chemistry
Exploiting Mitochondrial Vulnerabilities to Trigger Apoptosis Selectively in Cancer Cells
Christopher C. Nguyen, Siyaram Pandey · 2019 · Cancers
Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis
Jing-Ru Bai, Tong Liu, Bo Tu, Meng Yuan, Zhaoqi Shu, Minghe Fan, Si-Han Huo, Yuyao Guo, Li-Na Wang, Hua Wang et al. · 2022 · Autophagy
Hyaluronic acid fuels pancreatic cancer cell growth
Kim, Peter K, Halbrook, Christopher J, Kerk, Samuel A, Radyk, Megan, Wisner, Stephanie, Kremer, Daniel M, Sajjakulnukit, Peter, Andren, Anthony, Hou, Sean W, Trivedi, Ayush et al. · 2021 · eLife
Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics
Divya Murthy, Kuldeep Singh Attri, Pankaj K. Singh · 2018 · Frontiers in Physiology
Reproducible Automated Phosphopeptide Enrichment Using Magnetic TiO2 and Ti-IMAC
Christopher J. Tape, Jonathan D. Worboys, John Sinclair, Robert Gourlay, Janis Vogt, Kelly M. McMahon, Matthias Trost, Douglas A. Lauffenburger, Douglas J. Lamont, Claus Jørgensen · 2014 · Analytical Chemistry
Understanding metabolism with flux analysis: From theory to application
Ziwei Dai, Jason W. Locasale · 2016 · Metabolic Engineering
Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer
Chien, Wenwen, Sun, Qiao-Yang, Lee, Kian Leong, Ding, Ling-Wen, Wuensche, Peer, Torres-Fernandez, Lucia A., Tan, Siew Zhuan, Tokatly, Itay, Zaiden, Norazean, Poellinger, Lorenz et al. · 2015 · Molecular Oncology
A Review on Annona muricata and Its Anticancer Activity
Ilango, Suganya, Sahoo, Dipak Kumar, Paital, Biswaranjan, Kathirvel, Kavibharathi, Gabriel, Jerrina Issac, Subramaniam, Kalyani, Jayachandran, Priyanka, Dash, Rajendra Kumar, Hati, Akshaya Kumar, Behera, Tapas Ranjan et al. · 2022 · Cancers
Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response
Roberta Palorini, Francesco Paolo Cammarata, Chiara Balestrieri, Andrea Monestiroli, Michele Vasso, Cecilia Gelfi, Lilia Alberghina, Ferdinando Chiaradonna · 2013 · Cell Death and Disease
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer
Pat Gulhati, Aislyn P. Schalck, Shan Jiang, Xiaoying Shang, Chang‐Jiun Wu, Pingping Hou, Sharia Hernández Ruiz, Luisa M. Solis Soto, Edwin Roger Parra, Haoqiang Ying et al. · 2022 · Nature Cancer
Retraction Note to: Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer
Haifeng Zong, Yang Zhang, Yong You, Tiantian Cai, Yehuang Wang · 2015 · Medical Oncology · Retracted
Metabolic dependencies and vulnerabilities in leukemia
Marissa Rashkovan, Adolfo A. Ferrando · 2019 · Genes & Development
GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling
Ideno, Noboru, Yamaguchi, Hiroshi, Ghosh, Bidyut, Gupta, Sonal, Okumura, Takashi, Steffen, Dana J., Fisher, Catherine G., Wood, Laura D., Singhi, Aatur D., Nakamura, Masafumi et al. · 2018 · Gastroenterology
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer
Christina R Adams, Htet Htwe Htwe, Timothy Marsh, Aprilgate L Wang, Megan L. Montoya, Lakshmipriya Subbaraj, Aaron D. Tward, Nabeel M. Bardeesy, Rushika M. Perera · 2019 · eLife
Pancreatic tumor cell metabolism: Focus on glycolysis and its connected metabolic pathways
Fabienne Guillaumond, Juan Iovanna, Sophie Vasseur · 2014 · Archives of Biochemistry and Biophysics
Retinoblastoma protein promotes oxidative phosphorylation through upregulation of glycolytic genes in oncogene‐induced senescent cells
Takebayashi, Shin‐ichiro, Tanaka, Hiroshi, Hino, Shinjiro, Nakatsu, Yuko, Igata, Tomoka, Sakamoto, Akihisa, Narita, Masashi, Nakao, Mitsuyoshi · 2015 · Aging Cell
The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4
Celine Marques Pinheiro, Vera Miranda‐Gonçalves, Adhemar Longatto‐Filho, Anna Luiza Silva Almeida Vicente, Gustavo Nóriz Berardinelli, Cristovam Scapulatempo‐Neto, Ricardo Filipe Alves Costa, Cristiano Ribeiro Viana, Rui Manuel Reis, Fátima Baltazar et al. · 2016 · Cell Cycle
Metabolic Dependencies in Pancreatic Cancer
Ali Vaziri Gohar, Mahsa Zarei, Jonathan Robert Brody, Jordan Michael Winter · 2018 · Frontiers in Oncology
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Qinglong Ma, Wenyang Zhang, Kongming Wu, Lei Shi · 2025 · Molecular Cancer
MRI with hyperpolarised [1- 13 C]pyruvate detects advanced pancreatic preneoplasia prior to invasive disease in a mouse model
Eva Mendes Serrão, Mikko I. Kettunen, Tiago B. Rodrigues, Piotr Dzien, Alan J. Wright, Aarthi Gopinathan, Ferdia Aidan Gallagher, David Y. Lewis, Kristopher K. Frese, Jaime Almeida et al. · 2015 · Gut
Hyaluronan‐CD44/RHAMM interaction‐dependent cell proliferation and survival in lung cancer cells
Jung Min Song, Jintaek Im, Richard Seonghun Nho, Yong Hwan Han, Pramod Upadhyaya, Fekadu Kassie · 2018 · Molecular Carcinogenesis
HRAS‐driven cancer cells are vulnerable to TRPML1 inhibition
Jewon Jung, Kwang‐Jin Cho, Ali K. Naji, Kristen Clemons, Ching‐On Wong, Mariana Villanueva, Steven Gregory, Nicholas E. Karagas, Lingxiao Tan, Liang Hong et al. · 2019 · EMBO Reports
GLUT and HK: Two primary and essential key players in tumor glycolysis
Dhiraj Yadav, Anubha Yadav, Sujata Bhattacharya, Akansha Dagar, Vinit Kumar, Reshma Rani · 2024 · Seminars in Cancer Biology
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, Zhen Cao, Qiyao Zhang, Ziwen Liu · 2024 · Cell Death and Disease
Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes
Junjian Wang, Zhijian Duan, Zoann Jane Nugent, June X. Zou, Alexander D. Borowsky, Yanhong Zhang, Clifford G. Tepper, Jian Jian Li, Oliver Fiehn, Jianzhen Xu et al. · 2016 · Cancer Letters
Transcriptional Regulation of Energy Metabolism in Cancer Cells
Sara Rodríguez‐Enríquez, Álvaro Marín‐Hernández, Juan Carlos Gallardo‐Pérez, Silvia Cecilia Pacheco-Velázquez, Javier Belmont-Díaz, Diana Xochiquetzal Robledo‐Cadena, Jorge Luis Vargas-Navarro, Norma Angélica Corona de la Peña, Emma Saavedra, Rafael Moreno‐Sánchez · 2019 · Cells
Metabolic detection and systems analyses of pancreatic ductal adenocarcinoma through machine learning, lipidomics, and multi-omics
Guangxi Wang, Hantao Yao, Yan Gong, Zipeng Lu, Ruifang Pang, Yang Li, Yuyao Yuan, Huajie Song, Jia Liu, Yan Jin et al. · 2021 · Science Advances
IL-17A-producing CD8 + T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts
Felix S.R. Picard, Veronika Lutz, Anna I. Brichkina, Felix Neuhaus, Teresa Ruckenbrod, Anna Hupfer, Hartmann Raifer, Matthias Klein, Tobias Bopp, Petra Ina Pfefferle et al. · 2023 · Gut
Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS
Guowei Yin, Jing Huang, Johnny Petela, Hongmei Jiang, Yuetong Zhang, Siqi Gong, Jiaxin Wu, Bei Liu, Jianyou Shi, Yijun Gao · 2023 · Signal Transduction and Targeted Therapy
Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
Albrecht Neeße, Thomas Mathias Gress, David A. Tuveson, Patrick Michl, Sebastian Krug · 2013 · OncoTargets and Therapy
Oncogene-Driven Metabolic Alterations in Cancer
Hye‐Young Min, Ho‐Young Lee · 2017 · Biomolecules & Therapeutics
Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes
Leung, Kevin K., Wilson, Gary M., Kirkemo, Lisa L., Riley, Nicholas M., Coon, Joshua J., Wells, James A. · 2020 · Proceedings of the National Academy of Sciences
Novel therapeutic targets for pancreatic cancer
Shing-Chun Tang · 2014 · World Journal of Gastroenterology
ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer
Armen Gharibi, Sa La Kim, Justin Molnar, Daniel Brambilla, Yvess Adamian, Malachia Y. Hoover, Julie Hong, Joy Lin, Laurelin Wolfenden, Jonathan A. Kelber · 2017 · Scientific Reports
p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis
Fang Wang, Xiao-Mei Qi, Ryan Wertz, Matthew Mortensen, Catherine E. Hagen, John Evans, Yuri M. Sheinin, Michael A. James, Pengyuan Liu, Susan Tsai et al. · 2020 · Cancer Research
Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma
Matthew Louis Hedberg, Corbett T. Berry, Ata S. Moshiri, Yan Xiang, Christopher J. Yeh, Cem Atillasoy, Brian C. Capell, John T. Seykora · 2022 · International Journal of Molecular Sciences
Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target
Zhao, Junpeng, Jin, Dandan, Huang, Mengxiang, Ji, Jie, Xu, Xuebing, Wang, Fei, Zhou, Lirong, Bao, Baijun, Jiang, Feng, Xu, Weisong et al. · 2024 · Frontiers in Cell and Developmental Biology
Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer
Óscar Aguilera, María Muñoz-Sagastibelza, Blanca Torrejón, Aurea Borrero‐Palacios, Laura del Puerto‐Nevado, Javier Martínez‐Useros, María Rodríguez‐Remírez, Sandra Zazo, Estela García, Mario F. Fraga et al. · 2016 · Oncotarget
Autophagy is required for PDAC glutamine metabolism
Juwon Seo, Jung‐Won Choi, So‐Yeon Lee, Suhyun Sung, Hyun Ju Yoo, Minji Kang, Heesun Cheong, Jaekyoung Son · 2016 · Scientific Reports
Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome
Adrián Benito, Ibrahim H. Polat, Verónique Noé, Carlos J. Ciudad, Silvia Marín, Marta Cascante · 2017 · Oncotarget
A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas
Shigekazu Murakami, Ivan Nemazanyy, Shannon M. White, Hengye Chen, Chan D.K. Nguyen, Garrett T. Graham, Dieter Saur, Mario Pende, Chunling Yi · 2019 · Developmental Cell
The Progress and Development of GLUT1 Inhibitors Targeting Cancer Energy Metabolism
Ying Meng, Xi Jin Xu, Hongyu Luan, Lei Li, Wenhao Dai, Zhiyu Li, Jinlei Bian · 2019 · Future Medicinal Chemistry
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
Caitlin A. McIntyre, Adrien Grimont, Jiwoon Park, Yinuo Meng, Whitney J. Sisso, Kenneth P. Seier, Gun Ho Jang, Henry S. Walch, Victoria G. Aveson, David J. Falvo et al. · 2024 · Cancer Cell
Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells
Laura Brunelli, Elisa Caiola, Mirko Marabese, Massimo Broggini, Roberta Pastorelli · 2014 · Oncotarget
Concepts to Target MYC in Pancreatic Cancer
Matthias Wirth, Siavosh Mahboobi, Oliver Holger Krämer, Günter Schneider · 2016 · Molecular Cancer Therapeutics
Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer
Douglas E. Biancur, Kevin S. Kapner, Keisuke Yamamoto, Robert S. Banh, Jasper Edgar Neggers, Albert S.W. Sohn, Warren Wu, Robert T. Manguso, Adam Brown, David E. Root et al. · 2020 · Cell Metabolism
Dependence of Tumor Cell Lines and Patient-Derived Tumors on the NAD Salvage Pathway Renders Them Sensitive to NAMPT Inhibition with GNE-618
Yang Xiao, Kristi Elkins, Jenni Durieux, Leslie B. Lee, Jason Oeh, Lulu Yang, Xiaorong Liang, Chris DelNagro, Jarrod R. Tremayne, Mandy Kwong et al. · 2013 · Neoplasia
Progesterone Receptor Signaling in the Microenvironment of Endometrial Cancer Influences Its Response to Hormonal Therapy
Deanna M. Janzen, Miguel A. Rosales, Daniel Y. Paik, Daniel S. Lee, Daniel Arnold Smith, Owen N. Witte, M. Luisa Iruela‐Arispe, Sanaz Memarzadeh · 2013 · Cancer Research
Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance
Costas Andreas Lyssiotis, Jaekyoung Son, Lewis C. Cantley, Alec C. Kimmelman · 2013 · Cell Cycle
Eukaryotic Translation Initiation Factor 5A (EIF5A) Regulates Pancreatic Cancer Metastasis by Modulating RhoA and Rho-associated Kinase (ROCK) Protein Expression Levels
Ken Fujimura, Sunkyu Choi, Meghan M. Wyse, Ján Strnádel, Tracy Wright, Richard L. Klemke · 2015 · Journal of Biological Chemistry
Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer
Jun Zhao, Zhilan Xiao, Tingting Li, Huiqin Chen, Ying Yuan, Yanru Wang, Cheng-Hui Hsiao, Diana S‐L Chow, Willem W. Overwijk, Chun Li · 2018 · ACS Nano
Predictive Power of a Radiomic Signature Based on 18F-FDG PET/CT Images for EGFR Mutational Status in NSCLC
Xiaofeng Li, Guotao Yin, Yufan Zhang, Dong Dai, Jianjing Liu, Peihe Chen, Lei Zhu, Wenjuan Ma, Wengui Xu · 2019 · Frontiers in Oncology
Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
Allison N. Lau, Zhaoqi Li, Laura V. Danai, Anna M. Westermark, Alicia M. Darnell, Raphaël Ferreira, Vasilena Gocheva, Sharanya Sivanand, Evan C. Lien, Kiera M. Sapp et al. · 2020 · eLife
Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
Gabriela Reyes‐Castellanos, Rawand Masoud, Alice Carrier · 2020 · Biomedicines
MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype
Vincent Tambay, Valérie‐Ann Raymond, Marc Bilodeau · 2021 · Cancers